Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00084409 · ClinicalTrials.gov registry record · Phase 2
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
A Phase 2 study of Lung Cancer and Precancerous Condition, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 152
- Enrollment target
- 6
- Study locations
NCT00084409 is a Phase 2 study of Lung Cancer and Precancerous Condition that has completed, run by University of Colorado, Denver. The registered enrollment target is 152 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT00084409, a Phase 2 study of Lung Cancer and Precancerous Condition, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 152 participants
- Enrollment target
- 6
- Study locations
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Iloprost may be effective in preventing lung cancer. PURPOSE: This randomized phase II trial is studying how well iloprost works in preventing lung cancer in patients who are at high risk for this disease.
Conditions Studied
Interventions
- OTHER placebo
- DRUG iloprost
Study Locations (6)
Colorado
- University of Colorado Cancer Center at UC Health Sciences Center - Aurora
- Veterans Affairs Medical Center - Denver - Denver
Maryland
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore
Minnesota
- Mayo Clinic Cancer Center - Rochester
Pennsylvania
- UPMC Cancer Centers - Pittsburgh
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2001-11 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00084409
The ClinicalTrials.gov registry entry for NCT00084409 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00084409 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Colorado, Maryland, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00084409 about?
NCT00084409 is a clinical study titled "Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Iloprost may be effective in preventing lung cancer. PURPOSE: This randomized phase II trial is studying how well iloprost works in preventing lung cancer in patients who are at...
What is the current status of trial NCT00084409?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 152 participants. The study started on 2001-11. Estimated completion is 2009-01.
What conditions does trial NCT00084409 study?
This clinical trial studies the following conditions: Lung Cancer, Precancerous Condition.
What interventions are being tested in trial NCT00084409?
The interventions under investigation include: placebo (OTHER), iloprost (DRUG).
Who is sponsoring clinical trial NCT00084409?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00084409 being conducted?
This trial has 6 study locations across Colorado, Maryland, Minnesota, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Novel Treatment Combinations in Patients With Lung Cancer
RECRUITING · Phase 2
-
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
RECRUITING · Phase 2
-
ATATcH Alternating Treatment Plans for Advanced Cancer
RECRUITING · Phase 2
-
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
RECRUITING · Phase 2
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
-
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.